This is a $18,921.34 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the provision of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of July 10, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA, supplying a wide range of pharmaceutical products, medical supplies, and healthcare equipment in...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML SYRINGEML. The $7,852.35 contract has a completion date of March 8, 2024 and does not utilize a set-aside. Dakota Drug, Inc. is an experienced prime contractor to the DLA, providing a wide range of pharmaceutical products and medical supplies to support the medical needs of the U.S....
This is a $8,546.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of Stelara 90 mg/mL syringes, a biologic drug used to treat autoimmune conditions. There is no set-aside designation for this contract. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the DLA, providing a wide range of pharmaceutical products, medical supplies,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML SYRINGEML. The $11,087.94 contract has a completion date of March 21, 2024 and does not utilize a set-aside. Dakota Drug, Inc. has over two decades of experience providing a wide range of pharmaceutical products and medical supplies to support the DLA Troop Support Medical's mission of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $10,986.80 contract is for the supply of STELARA 90 MG/ML syringes, a biologic medication used to treat rheumatoid arthritis and other medical conditions. This delivery order is issued against Dakota Drug, Inc.'s blanket purchase agreement and other DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract is for the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions. The contract has a ceiling value of $10,534.93 and a period of performance through April 17, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,421.40, is for the supply of Stelara 90 mg/mL syringes, a prescription medication used to treat various autoimmune conditions. This award is not associated with a set-aside program. The DLA Troop Support Medical is responsible for providing comprehensive medical supply chain...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,388.98 contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through March 29, 2024. This contract does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA Troop Support Medical, having provided a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to the prime contractor Dakota Drug, Inc. The $9,826.08 firm fixed-price delivery order covers the supply of STELARA 90 MG/ML syringes, a biologic drug used to treat autoimmune conditions. The contract has a period of performance through May 30, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range of...